Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
2013 · American Journal of Transplantation · 180 citations
https://doi.org/10.1111/ajt.12280
C
Christophe Duvoux
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
276
Papers
12.3K
Citations
56
h-index
142
i10-index
Christophe Duvoux is an academic researcher from Université Paris-Est Créteil. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Organ Transplantation Techniques and Outcomes. The author has an h-index of 56, co-authored 235 publications.
ORCID: 0000-0003-4625-4279Papers by this author
worksA prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
2010 · BMC Cancer · 159 citations
https://doi.org/10.1186/1471-2407-10-190
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
2022 · Research Portal (King's College London) · 120 citations
https://doi.org/10.1016/s2468-1253
Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system
2011 · Liver Transplantation · 97 citations
https://doi.org/10.1002/lt.22363
Artificial Intelligence and liver: Opportunities and barriers
2023 · Digestive and Liver Disease · 36 citations
https://doi.org/10.1016/j.dld.2023.08.048
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
2022 · JHEP Reports · 34 citations
https://doi.org/10.1016/j.jhepr.2022.100445
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat